Review of Foreign-Trade Zone Activity, Foreign-Trade Subzone 43D, Perrigo Company, Battle Creek Michigan, (Ibuprofen-Pharmaceutical Products), 54521 [05-18353]
Download as PDF
Federal Register / Vol. 70, No. 178 / Thursday, September 15, 2005 / Notices
National Forest, Detroit Ranger District,
HC 73 Box 320, Mill City, OR 97360;
(503) 854–3366.
Dated: September 9, 2005.
Dallas J. Emch,
Forest Supervisor.
[FR Doc. 05–18315 Filed 9–14–05; 8:45 am]
BILLING CODE 3410–11–M
DEPARTMENT OF AGRICULTURE
Forest Service
Notice of Sanders County Resource
Advisory Committee Meeting
Forest Service, USDA.
Notice of meeting.
AGENCY:
ACTION:
SUMMARY: Pursuant to the authorities in
the Federal Advisory Committee Act
(Public Law 92–463) and under the
Secure Rural Schools and Community
Self-Determination Act of 2000 (Public
Law 106–393) the Lolo and Kootenai
National Forests’ Sanders County
Resource Advisory Committee will meet
on September 15 at 7 p.m. in Thompson
Falls, Montana for a business meeting.
The meeting is open to the public.
DATES: September 15, 2005.
ADDRESSES: The meeting will be held at
the Thompson Falls Courthouse, 1111
Main Street, Thompson Falls, MT
59873.
FOR FURTHER INFORMATION CONTACT:
Randy Hojem, Designated Federal
Official (DFO), District Ranger, Plains
Ranger District, Lolo National Forest at
(406) 826–3821.
SUPPLEMENTARY INFORMATION: Agenda
topics include reviewing and making
recommendations on proposed RAC
projects for 2006, and receiving public
comment. If the meeting location is
changed, notice will be posted in the
local newspapers, including the Clark
Fork Valley Press, and Sanders County
Ledger.
Dated: September 2, 2005.
Randy Hojem,
DFO, Plains Ranger District, Lolo National
Forest.
[FR Doc. 05–18291 Filed 9–14–05; 8:45 am]
BILLING CODE 3410–11–M
DEPARTMENT OF AGRICULTURE
Forest Service
Notice of Southwest Idaho Resource
Advisory Committee Meeting
Forest Service, USDA.
Notice of meeting.
AGENCY:
ACTION:
VerDate Aug<18>2005
15:03 Sep 14, 2005
Jkt 205001
SUMMARY: Pursuant to the authorities in
the Federal Advisory Committee Act
(Pub. L. 92–463) and under the Secure
Rural Schools and Community SelfDetermination Act of 2000 (Pub. L. 106–
393), the Boise and Payette National
Forests’ Southwest Idaho Resource
Advisory Committee will conduct a
business meeting, which is open to the
public.
DATES: Wednesday, September 21, 2005,
beginning at 11 a.m.
ADDRESSES: USDA Forest Service,
Payette National Forest, Council Ranger
District, 500 East Whitely Avenue,
Council, Idaho.
SUPPLEMENTARY INFORMATION: Agenda
topics will include review and approval
of project proposals, and is an open
public forum.
FOR FURTHER INFORMATION CONTACT:
Doug Gochnour, Designated Federal
Officer, at 208–392–6681 or e-mail
dgochnour@fs.fed.us.
Dated: September 9, 2005.
Richard A. Smith,
Forest Supervisor, Boise National Forest.
[FR Doc. 05–18318 Filed 9–14–05; 8:45 am]
BILLING CODE 3410–11–M
DEPARTMENT OF COMMERCE
Foreign–Trade Zones Board
[Docket 43–2005]
Review of Foreign–Trade Zone
Activity, Foreign–Trade Subzone 43D,
Perrigo Company, Battle Creek
Michigan, (Ibuprofen–Pharmaceutical
Products)
Pursuant to authority under the
Foreign–Trade Zones (FTZ) Act, as
amended (19 U.S.C. 81a–81u), including
Section 81(o)(c), and the regulations of
the FTZ Board (15 CFR part 400), to
monitor, review, and restrict activity
affecting foreign–trade zone
merchandise, a review is being initiated
of activity related to certain
merchandise at Foreign–Trade Subzone
43D, at the pharmaceutical products
manufacturing facilities of the Perrigo
Company, in the Battle Creek, Michigan,
area.
In May 2003, the FTZ Board filed an
application from the City of Battle
Creek, Michigan, grantee of FTZ 43,
requesting special–purpose subzone
status with certain manufacturing
authority for Perrigo. Subzone 43D was
approved by the Foreign–Trade Zones
(FTZ) Board on April 13, 2004 (Board
Order 1326, 69 FR 21498, 4/21/04). The
activity authorized by the FTZ Board
included manufacturing over–the-
PO 00000
Frm 00002
Fmt 4703
Sfmt 4703
54521
counter pharmaceutical products
containing ibuprofen, aspirin and
acetaminophen. Subsequent to the
issuance of the Board Order, additional
information emerged which raised
potential issues with respect to some of
the ibuprofen–related information
presented in the Perrigo application;
that application had been among the
bases for the FTZ Board’s approval of
manufacturing at Subzone 43D. The
FTZ staff then conducted a preliminary
inquiry into the matter and found that
the additional information appeared to
raise questions that warranted
consideration by the FTZ Board.
The FTZ Board’s review in this matter
will consider whether new information
requires modification of the authority
granted for Subzone 43D with respect to
ibuprofen and products containing
ibuprofen. The review will focus
primarily on updated information
regarding: Perrigo’s ibuprofen sourcing
patterns and plans, and industry–wide
patterns; international competition in
finished products containing ibuprofen;
potential effects on domestic suppliers;
the scope of FTZ benefits for Perrigo;
and the net economic effect of Perrigo’s
use of FTZ procedures with respect to
these products.
Public comment is invited from
interested parties. Information
submitted for the record generally
should be in a non–proprietary format.
If there is a need to submit business
proprietary information, it should be
appropriately marked and accompanied
by a public version. Submissions
(original and 3 copies) shall be
addressed to the Board’s Executive
Secretary at one of the following
addresses:
1. Submissions Via Express/Package
Delivery Services: Foreign–Trade-Zones
Board, U.S. Department of Commerce,
Franklin Court Building - Suite 4100W,
1099 14th St. NW, Washington, D.C.
20005; or
2. Submissions Via the U.S. Postal
Service: Foreign–Trade-Zones Board,
U.S. Department of Commerce, FCB Suite 4100W, 1401 Constitution Ave.
NW, Washington, D.C. 20230.
The closing period for their receipt is
November 14, 2005.
Dated: September 8, 2005.
Dennis Puccinelli,
Executive Secretary.
[FR Doc. 05–18353 Filed 9–14–05; 8:45 am]
Billing Code: 3510–DS–S
E:\FR\FM\15SEN1.SGM
15SEN1
Agencies
[Federal Register Volume 70, Number 178 (Thursday, September 15, 2005)]
[Notices]
[Page 54521]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-18353]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[Docket 43-2005]
Review of Foreign-Trade Zone Activity, Foreign-Trade Subzone 43D,
Perrigo Company, Battle Creek Michigan, (Ibuprofen-Pharmaceutical
Products)
Pursuant to authority under the Foreign-Trade Zones (FTZ) Act, as
amended (19 U.S.C. 81a-81u), including Section 81(o)(c), and the
regulations of the FTZ Board (15 CFR part 400), to monitor, review, and
restrict activity affecting foreign-trade zone merchandise, a review is
being initiated of activity related to certain merchandise at Foreign-
Trade Subzone 43D, at the pharmaceutical products manufacturing
facilities of the Perrigo Company, in the Battle Creek, Michigan, area.
In May 2003, the FTZ Board filed an application from the City of
Battle Creek, Michigan, grantee of FTZ 43, requesting special-purpose
subzone status with certain manufacturing authority for Perrigo.
Subzone 43D was approved by the Foreign-Trade Zones (FTZ) Board on
April 13, 2004 (Board Order 1326, 69 FR 21498, 4/21/04). The activity
authorized by the FTZ Board included manufacturing over-the-counter
pharmaceutical products containing ibuprofen, aspirin and
acetaminophen. Subsequent to the issuance of the Board Order,
additional information emerged which raised potential issues with
respect to some of the ibuprofen-related information presented in the
Perrigo application; that application had been among the bases for the
FTZ Board's approval of manufacturing at Subzone 43D. The FTZ staff
then conducted a preliminary inquiry into the matter and found that the
additional information appeared to raise questions that warranted
consideration by the FTZ Board.
The FTZ Board's review in this matter will consider whether new
information requires modification of the authority granted for Subzone
43D with respect to ibuprofen and products containing ibuprofen. The
review will focus primarily on updated information regarding: Perrigo's
ibuprofen sourcing patterns and plans, and industry-wide patterns;
international competition in finished products containing ibuprofen;
potential effects on domestic suppliers; the scope of FTZ benefits for
Perrigo; and the net economic effect of Perrigo's use of FTZ procedures
with respect to these products.
Public comment is invited from interested parties. Information
submitted for the record generally should be in a non-proprietary
format. If there is a need to submit business proprietary information,
it should be appropriately marked and accompanied by a public version.
Submissions (original and 3 copies) shall be addressed to the Board's
Executive Secretary at one of the following addresses:
1. Submissions Via Express/Package Delivery Services: Foreign-Trade-
Zones Board, U.S. Department of Commerce, Franklin Court Building -
Suite 4100W, 1099 14th St. NW, Washington, D.C. 20005; or
2. Submissions Via the U.S. Postal Service: Foreign-Trade-Zones Board,
U.S. Department of Commerce, FCB - Suite 4100W, 1401 Constitution Ave.
NW, Washington, D.C. 20230.
The closing period for their receipt is November 14, 2005.
Dated: September 8, 2005.
Dennis Puccinelli,
Executive Secretary.
[FR Doc. 05-18353 Filed 9-14-05; 8:45 am]
Billing Code: 3510-DS-S